title: Principles of clinically important drug interactions with carbamazepine. Part I.
authors.affiliation: Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892.
authors.forename: T A
authors.initials: TA
authors.lastname: Ketter
authors.forename: R M
authors.initials: RM
authors.lastname: Post
authors.forename: K
authors.initials: K
authors.lastname: Worthington
mesh_terms: D000700:Analgesics / Q000494:pharmacology; D000777:Anesthetics / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002220:Carbamazepine / Q000493:pharmacokinetics / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology
chemical_list: D000700:Analgesics; D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002220:Carbamazepine